Alternatives to N-Zyme Biomedical
N-Zyme Biomedical is a Biotechnology tool: a biotechnology company focused on developing novel enzyme-based therapies for reflux disease. Here are the 2 closest alternatives, compared on pricing, features and what real users say.
The 2 closest alternatives to N-Zyme Biomedical
Ranked by how closely each one overlaps with N-Zyme Biomedical on category and features.
- 1
Spark Therapeutics
BiotechnologyA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Pricing:
- Contact for pricing
- Reddit:
- 33% positive(3 mentions)how we count
- 2
Developing novel immunotherapies and diagnostics for cancer.
- Pricing:
- Contact for pricing
- Reddit:
- 100% positive(6 mentions)how we count
Community sentiment is our own count of how positive, negative or neutral the discussions we track about each tool are, across the subreddits where its users actually post. It is not a star rating and it is not a review score. Pricing reflects each vendor's public plans and can change, so check the provider for the current price.
We track only 2 close alternatives to N-Zyme Biomedical so far. Browse more Biotechnology alternatives while this list fills out.
The 20 closest Biotechnology companies to N-Zyme Biomedical
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8M
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website ImmunoScape58BiotechnologySingapore, Singapore$49.7M
Developing novel immunotherapies and diagnostics for cancer.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Anagram Therapeutics55BiotechnologyNatick, USA$285.0MClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Showing the 20 closest matches. See the rest on the N-Zyme Biomedical profile.
N-Zyme Biomedical alternatives: common questions
What are the closest alternatives to N-Zyme Biomedical?
Spark Therapeutics, ImmunoScape are the closest alternatives to N-Zyme Biomedical by feature overlap and category. Each one is compared above on pricing, features and community sentiment.